A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms
- DOI
- 10.1038/s41416-026-03488-w
- Published
- 2026-06-04
- Container
- British Journal of Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-026-03488-w,
title = {A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms},
author = {T. R. Jeffry Evans and Natalie Cook and Anthony El-Khoueiry and David J. Pinato and Nguyen H. Tran and David Hsiehchen and Edward Mena and Tim Meyer and Jincao Wu and Shriram M. Pathak and Costanza Paoletti and Lea Dutta and Chinyere E. Okpara and Juanita S. Lopez},
year = {2026},
journal = {British Journal of Cancer},
doi = {10.1038/s41416-026-03488-w},
url = {https://doi.org/10.1038/s41416-026-03488-w}
}RIS
TY - JOUR TI - A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms AU - T. R. Jeffry Evans AU - Natalie Cook AU - Anthony El-Khoueiry AU - David J. Pinato AU - Nguyen H. Tran AU - David Hsiehchen AU - Edward Mena AU - Tim Meyer AU - Jincao Wu AU - Shriram M. Pathak AU - Costanza Paoletti AU - Lea Dutta AU - Chinyere E. Okpara AU - Juanita S. Lopez PY - 2026 JO - British Journal of Cancer DO - 10.1038/s41416-026-03488-w UR - https://doi.org/10.1038/s41416-026-03488-w ER -
APA
Evans, T. R. J., Cook, N., El-Khoueiry, A., Pinato, D. J., Tran, N. H., Hsiehchen, D., Mena, E., Meyer, T., Wu, J., Pathak, S. M., Paoletti, C., Dutta, L., Okpara, C. E., & Lopez, J. S. (2026). A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03488-w
Source records
- crossref · retrieved 2026-09-26T19:19:29.595Z